These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Strengthening Biorisk Management Capacities in Burkina Faso: Contribution of the Global Health Security Agenda. Dama E, Orelle A, Nikiema A, Mandingar PD, Naby A, Bationo GB, Kéita MS, Pierson A, Sawadogo C, Koné RG. Health Secur; 2022; 20(6):479-487. PubMed ID: 36399610 [Abstract] [Full Text] [Related]
5. A Cross-Sectional Survey to Assess Biorisk Management System in Research and Diagnostic Laboratories in Khyber Pakhtunkhwa, Pakistan. Muhammad J, Sarwar S, Khan T, Qasmi SA, Ikram A, Ahmad G, Zahid M, Durrani RH, Ahmed F. Front Public Health; 2021; 9():766162. PubMed ID: 34976925 [Abstract] [Full Text] [Related]
8. Biosafety and biosecurity as essential pillars of international health security and cross-cutting elements of biological nonproliferation. Bakanidze L, Imnadze P, Perkins D. BMC Public Health; 2010 Dec 03; 10 Suppl 1(Suppl 1):S12. PubMed ID: 21143822 [Abstract] [Full Text] [Related]
9. [Biorisk Management for Clinical Diagnostic Laboratories]. Shigematsu M. Rinsho Byori; 2016 Nov 03; 64(11):1279-1289. PubMed ID: 30695310 [Abstract] [Full Text] [Related]
10. Accelerating Action in Global Health Security: Global Biosecurity Dialogue as a Model for Advancing the Global Health Security Agenda. Brizee S, Budeski K, James W, Nalabandian M, Bleijs DA, Becker SJ, Wallace-Sankarsingh S, Ahumibe A, Agogo E, Ihekweazu C, Nikkari S, Ellis M, Gozzer E, Semesi IS, Masuku ZM, Ikram A, Tahir F, Makalinao I, Severance HA, van Passel MWJ, Cameron EE. Health Secur; 2019 Nov 03; 17(6):495-503. PubMed ID: 31859570 [Abstract] [Full Text] [Related]
11. Motivating Proactive Biorisk Management. Greene D, Palmer MJ, Relman DA. Health Secur; 2023 Nov 03; 21(1):46-60. PubMed ID: 36633603 [Abstract] [Full Text] [Related]
12. Assessment of the Biosafety and Biosecurity Landscape in the Philippines and the Development of the National Biorisk Management Framework. Destura RV, Lam HY, Navarro RC, Lopez JCF, Sales RKP, Gomez MIFA, Dela Tonga A, Ulanday GE. Appl Biosaf; 2021 Dec 01; 26(4):232-244. PubMed ID: 36034094 [Abstract] [Full Text] [Related]
13. Biosafety and biosecurity measures: management of biosafety level 3 facilities. Zaki AN. Int J Antimicrob Agents; 2010 Nov 01; 36 Suppl 1():S70-4. PubMed ID: 20801002 [Abstract] [Full Text] [Related]
14. A Mentorship Program to Develop Biorisk Manuals for Laboratories in Pakistan. Sarwar S, Moreno MMN, Chaudhri M, Aamir UB, Ikram A. Appl Biosaf; 2022 Dec 01; 27(4):219-224. PubMed ID: 36761992 [Abstract] [Full Text] [Related]
15. Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility. Joseph T, Phyu S, Se-Thoe SY, Chu JJH. Methods Mol Biol; 2022 Dec 01; 2452():441-464. PubMed ID: 35554920 [Abstract] [Full Text] [Related]
16. Systematic approach towards establishing a National Inventory of Dangerous Pathogens. Vennis IM, Bleijs DA, Brizee S, Van Den Berg HHJL, Kampert E, Rutjes SA, Van Passel MWJ. Glob Health Action; 2021 Jan 01; 14(1):1971866. PubMed ID: 34493169 [Abstract] [Full Text] [Related]
17. Comparison of Brazilian High- and Maximum-Containment Laboratories Biosafety and Biosecurity Regulations to Legal Frameworks in the United States and Other Countries: Gaps and Opportunities. Mendonça AO, Zuelke KA, Kahl-Mcdonagh MM, Mafra C. Appl Biosaf; 2024 Mar 01; 29(1):45-56. PubMed ID: 38434103 [Abstract] [Full Text] [Related]
18. National Biosafety Management System: A Combined Framework Approach Based on 15 Key Elements. Orelle A, Nikiema A, Zakaryan A, Albetkova AA, Rayfield MA, Peruski LF, Pierson A, Kachuwaire O. Front Public Health; 2021 Mar 01; 9():609107. PubMed ID: 34368035 [Abstract] [Full Text] [Related]
19. China's evolving biosafety/biosecurity legislations. Cao C. J Law Biosci; 2021 Mar 01; 8(1):lsab020. PubMed ID: 34221436 [Abstract] [Full Text] [Related]
20. The 2022 Russia invasion on Ukraine: The biofuel energy security challenge on Ukraine and some related countries. Esonye C, Esonye CO, Agha EO, Ume CS, Njemanze CV, Eyisi CE, Adepoju TF. Heliyon; 2023 Nov 01; 9(11):e21483. PubMed ID: 38027686 [Abstract] [Full Text] [Related] Page: [Next] [New Search]